等待开盘 09-18 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:Northland Capital Markets:维持BrainsWay"跑赢大市"评级,目标价从15美元升至19美元;Lake Street:维持Hyperfine"买入"评级,目标价从1.5美元升至2美元
08-15 09:30
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to $18.
08-15 01:44
Cellebrite shares are trading higher after the company reported better-than-exp...
08-14 22:10
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $121.000 million-$126.000 million vs $124.357 million analyst estimate.
08-14 19:03
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Cellebrite announced U.S. Department of Justice (DOJ) sponsorship to advance its Cellebrite Government Cloud (CGC) from FedRAMP High Ready to "In Process" status, a key step toward full Authorization to Operate (ATO). CGC will offer secure, cutting-edge cloud solutions, including Cellebrite Inseyets and Guardian, enhancing investigative workflows and operational efficiency for U.S. federal agencies.
07-23 12:30
The latest update is out from Cellebrite DI ( ($CLBT) ). Cellebrite announced t...
07-08 21:17
Cellebrite announced the appointment of David Barter as its new Chief Financial Officer, succeeding Dana Gerner, who is retiring after 11 years in the role. Barter brings over 30 years of experience in scaling global software companies, most recently at New Relic, where he helped drive growth to nearly $1 billion in annual revenue. Gerner will remain in an advisory role until the company reports its second-quarter 2025 financial results. Barter w...
07-08 12:30
Cellebrite has expanded its partnership with the National Center for Missing and Exploited Children (NCMEC) by integrating NCMEC's CyberTipline hash value list into its Cellebrite Insight digital forensics software. This integration enables investigators to quickly identify known child sexual abuse material (CSAM) files, accelerating investigations and protecting victims. The hash value list includes approximately 10 million confirmed CSAM files ...
06-24 20:01
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1138028221594226688.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital:维持Aemetis(AMTX)"买入"评级,目标价从19美元升至20美元</p> <p>• Ascendiant Capital:维持Lucid Diagnostics(LUCD)"买
06-07 08:37